Before lithium became available to treat this potentially devastating illness, bipolar I sufferers experienced repeated ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Scientists have pinpointed nearly 300 "hotspots" in the human genome that may increase the risk of bipolar disorder. In the largest study of its kind to date, an international research team conducted ...

Lithium carbonate and valproate sodium are each recommended as monotherapy for preventing relapses in patients with bipolar disorder and are sometimes used in combination. However, combination ...

The journey of mental health treatment has been a ... Around the same time, lithium was found to stabilize the intense mood swings of bipolar disorder, and early antidepressants, such as monoamine ...

One key message from this study is that lithium should remain the main treatment for bipolar disorder, while raising concerns about the use of antidepressant monotherapy as an effective long-term ...

Clinical practice guidelines identify lithium as a first line treatment for mood stabilization and reduction of suicidality in bipolar disorders (BD); however, most individuals show sub-optimal ...

Mental health is just as important as physical health, yet many people struggle to find the right treatment that meets their ...

Detailed price information for Sunshine Biopharma (SBFM-Q) from The Globe and Mail including charting and trades.